Baxter V, Heise M
Adv Virus Res. 2020; 107:315-382.
PMID: 32711733
PMC: 8224468.
DOI: 10.1016/bs.aivir.2020.06.002.
Ferguson M, Saul S, Fragkoudis R, Weisheit S, Cox J, Patabendige A
J Virol. 2015; 89(15):7536-49.
PMID: 25972559
PMC: 4505677.
DOI: 10.1128/JVI.03645-14.
Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F
PLoS Pathog. 2008; 4(2):e29.
PMID: 18282093
PMC: 2242832.
DOI: 10.1371/journal.ppat.0040029.
Fazakerley J, Boyd A, Mikkola M, Kaariainen L
J Virol. 2001; 76(1):392-6.
PMID: 11739703
PMC: 135702.
DOI: 10.1128/jvi.76.1.392-396.2002.
Dubuisson J, Lustig S, Ruggli N, Akov Y, Rice C
J Virol. 1997; 71(4):2636-46.
PMID: 9060616
PMC: 191385.
DOI: 10.1128/JVI.71.4.2636-2646.1997.
Pathogenesis of virus-induced demyelination.
Fazakerley J, Buchmeier M
Adv Virus Res. 1993; 42:249-324.
PMID: 8430521
PMC: 7131186.
DOI: 10.1016/s0065-3527(08)60087-1.
Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage.
Soilu-Hanninen M, Eralinna J, Hukkanen V, Roytta M, Salmi A, Salonen R
J Virol. 1994; 68(10):6291-8.
PMID: 7916058
PMC: 237049.
DOI: 10.1128/JVI.68.10.6291-6298.1994.
In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.
Subak-Sharpe I, Dyson H, Fazakerley J
J Virol. 1993; 67(12):7629-33.
PMID: 7901429
PMC: 238231.
DOI: 10.1128/JVI.67.12.7629-7633.1993.
Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?.
Webb H, Fazakerley J
Neuropathol Appl Neurobiol. 1984; 10(1):1-10.
PMID: 6330601
PMC: 7168014.
DOI: 10.1111/j.1365-2990.1984.tb00335.x.
Demyelination in mice resulting from infection with a mutant of Semliki Forest virus.
Sheahan B, Barrett P, Atkins G
Acta Neuropathol. 1981; 53(2):129-36.
PMID: 6259872
PMC: 7086517.
DOI: 10.1007/BF00689993.
Neurogenic spread of Semliki Forest virus in mice.
Kaluza G, Lell G, Reinacher M, Stitz L, Willems W
Arch Virol. 1987; 93(1-2):97-110.
PMID: 2434064
DOI: 10.1007/BF01313896.
Mouse hydrocephalus and encephalitis following intracerebral infection with Newcastle disease vaccine viruses.
Webb H
Br J Exp Pathol. 1976; 57(4):472-80.
PMID: 971410
PMC: 2041164.